We report interim data from patients with endometrial cancer (EC) participating in a phase I trial of single-agent dostarlimab. 17 Department of Obstetrics and Gynecology, NYU Langone Health, Perlmutter Cancer Center, New York University, New York, New York, USA.ĭostarlimab is a humanized monoclonal antibody that binds with high affinity to PD-1, resulting in inhibition of binding to PD-L1 and PD-L2. 16 GlaxoSmithKline, Waltham, Massachusetts, USA.15 O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.14 Department of Oncology, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.13 Department of Gynecological Oncology, University of Calgary, Calgary, Alberta, Canada.12 Georgia Cancer Center, Augusta University, Augusta, Georgia, USA.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |